Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04966663
Title Using ctDNA to Determine Therapies for Lung Cancer (ctDNA Lung RCT)
Recruitment Not yet recruiting
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto

lung non-small cell carcinoma


Carboplatin + Nivolumab + Pemetrexed Disodium

Cisplatin + Gemcitabine + Nivolumab

Cisplatin + Nivolumab + Pemetrexed Disodium

Carboplatin + Gemcitabine + Nivolumab

Age Groups: senior | adult
Covered Countries CAN

No variant requirements are available.